BR112014030993A2 - formulações tópicas, respectivo uso e método para tratar infecção de pele ou ferida - Google Patents
formulações tópicas, respectivo uso e método para tratar infecção de pele ou feridaInfo
- Publication number
- BR112014030993A2 BR112014030993A2 BR112014030993A BR112014030993A BR112014030993A2 BR 112014030993 A2 BR112014030993 A2 BR 112014030993A2 BR 112014030993 A BR112014030993 A BR 112014030993A BR 112014030993 A BR112014030993 A BR 112014030993A BR 112014030993 A2 BR112014030993 A2 BR 112014030993A2
- Authority
- BR
- Brazil
- Prior art keywords
- topical formulations
- treating skin
- wound infection
- infection
- wound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
formulações tópicas, respectivo uso e método para tratar infecção de pele ou ferida resumo a invenção proporciona formulações tópicas quimica e fisicamente estáveis de pexiganana e métodos para preparar as mesmas. 1/1
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/494,295 US8530409B1 (en) | 2012-06-12 | 2012-06-12 | Stable pexiganan formulation |
PCT/US2013/044957 WO2013188286A1 (en) | 2012-06-12 | 2013-06-10 | Stable pexiganan formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014030993A2 true BR112014030993A2 (pt) | 2017-06-27 |
Family
ID=49084089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014030993A BR112014030993A2 (pt) | 2012-06-12 | 2013-06-10 | formulações tópicas, respectivo uso e método para tratar infecção de pele ou ferida |
Country Status (27)
Country | Link |
---|---|
US (2) | US8530409B1 (pt) |
EP (1) | EP2858721B1 (pt) |
JP (1) | JP5876191B2 (pt) |
KR (1) | KR101622524B1 (pt) |
CN (1) | CN104602762B (pt) |
AU (1) | AU2013274561B2 (pt) |
BR (1) | BR112014030993A2 (pt) |
CA (1) | CA2876668C (pt) |
CY (1) | CY1118277T1 (pt) |
DK (1) | DK2858721T3 (pt) |
EA (1) | EA028002B1 (pt) |
ES (1) | ES2599395T3 (pt) |
HK (1) | HK1210078A1 (pt) |
HR (1) | HRP20161440T1 (pt) |
HU (1) | HUE030665T2 (pt) |
IL (1) | IL236151A (pt) |
LT (1) | LT2858721T (pt) |
MX (1) | MX345263B (pt) |
NZ (1) | NZ703176A (pt) |
PL (1) | PL2858721T3 (pt) |
PT (1) | PT2858721T (pt) |
RS (1) | RS55286B1 (pt) |
SG (1) | SG11201408055PA (pt) |
SI (1) | SI2858721T1 (pt) |
SM (1) | SMT201600411B (pt) |
WO (1) | WO2013188286A1 (pt) |
ZA (1) | ZA201500117B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8530409B1 (en) * | 2012-06-12 | 2013-09-10 | Dipexium Pharmaceuticals LLC | Stable pexiganan formulation |
GB201505393D0 (en) * | 2015-03-30 | 2015-05-13 | Secr Defence | Antimicrobal peptide formulations |
CN111925430B (zh) * | 2020-08-18 | 2022-05-24 | 中国海洋大学 | 抗菌肽及其应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4144346A (en) * | 1977-01-31 | 1979-03-13 | Janssen Pharmaceutica N.V. | Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles |
US4169703A (en) * | 1978-08-03 | 1979-10-02 | Syntex (U.S.A.) Inc. | Oxidative red hair dye |
US5912231A (en) * | 1989-07-07 | 1999-06-15 | Scripps Clinic And Research Foundation | Substitution analogues of magainin peptides |
TW460296B (en) * | 1994-09-01 | 2001-10-21 | Janssen Pharmaceutica Nv | Topical ketoconazole emulsion compositions without sodium sulfite |
US7530461B2 (en) * | 1995-03-10 | 2009-05-12 | Photocure Asa | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
EP1734925A2 (en) * | 2004-03-18 | 2006-12-27 | Panacea Biotec Ltd. | Novel compositions for topical delivery |
US20080260655A1 (en) * | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
WO2009070564A2 (en) * | 2007-11-27 | 2009-06-04 | Macrochem Corporation | Compositions and methods for prevention of infection in transcutaneous osseointegrated implants |
US8318817B2 (en) * | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
WO2012174373A1 (en) * | 2011-06-16 | 2012-12-20 | Dipexium Pharmaceuticals | Methods of treating and inhibiting pathogens with resistance-mechanisms |
US8530409B1 (en) * | 2012-06-12 | 2013-09-10 | Dipexium Pharmaceuticals LLC | Stable pexiganan formulation |
-
2012
- 2012-06-12 US US13/494,295 patent/US8530409B1/en not_active Expired - Fee Related
-
2013
- 2013-06-10 PT PT138036561T patent/PT2858721T/pt unknown
- 2013-06-10 ES ES13803656.1T patent/ES2599395T3/es active Active
- 2013-06-10 NZ NZ703176A patent/NZ703176A/en not_active IP Right Cessation
- 2013-06-10 HU HUE13803656A patent/HUE030665T2/en unknown
- 2013-06-10 SI SI201330366A patent/SI2858721T1/sl unknown
- 2013-06-10 BR BR112014030993A patent/BR112014030993A2/pt not_active IP Right Cessation
- 2013-06-10 WO PCT/US2013/044957 patent/WO2013188286A1/en active Application Filing
- 2013-06-10 LT LTEP13803656.1T patent/LT2858721T/lt unknown
- 2013-06-10 CN CN201380031162.5A patent/CN104602762B/zh not_active Expired - Fee Related
- 2013-06-10 AU AU2013274561A patent/AU2013274561B2/en not_active Ceased
- 2013-06-10 JP JP2015517332A patent/JP5876191B2/ja not_active Expired - Fee Related
- 2013-06-10 RS RS20160918A patent/RS55286B1/sr unknown
- 2013-06-10 DK DK13803656.1T patent/DK2858721T3/en active
- 2013-06-10 KR KR1020157000319A patent/KR101622524B1/ko not_active IP Right Cessation
- 2013-06-10 SG SG11201408055PA patent/SG11201408055PA/en unknown
- 2013-06-10 EP EP13803656.1A patent/EP2858721B1/en active Active
- 2013-06-10 CA CA2876668A patent/CA2876668C/en not_active Expired - Fee Related
- 2013-06-10 EA EA201492280A patent/EA028002B1/ru not_active IP Right Cessation
- 2013-06-10 MX MX2014015199A patent/MX345263B/es active IP Right Grant
- 2013-06-10 PL PL13803656T patent/PL2858721T3/pl unknown
- 2013-08-09 US US13/963,311 patent/US20140038882A1/en not_active Abandoned
-
2014
- 2014-12-09 IL IL236151A patent/IL236151A/en not_active IP Right Cessation
-
2015
- 2015-01-08 ZA ZA2015/00117A patent/ZA201500117B/en unknown
- 2015-11-02 HK HK15110786.0A patent/HK1210078A1/xx not_active IP Right Cessation
-
2016
- 2016-10-19 CY CY20161101058T patent/CY1118277T1/el unknown
- 2016-11-02 HR HRP20161440TT patent/HRP20161440T1/hr unknown
- 2016-11-15 SM SM201600411T patent/SMT201600411B/it unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3354257A4 (en) | COMPOSITION FOR IMPROVING SKIN AND PREVENTING HAIR LOSS WITH EXTRACELLULAR VESICLES FROM PLANT EXTRACTS | |
BR112014021104A2 (pt) | métodos e composições para o tratamento da doença de huntington | |
BR112013015498A2 (pt) | formulação localizada tópica, uso da formulação, e, método para tratamento ou profilaxia de infestação de parasita de um animal | |
MX2016005585A (es) | Exopolisacarido para el tratamiento y/o el cuidado de la piel, medios de cultivo y composiciones del mismo. | |
EP2827837B8 (en) | Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails | |
CL2015003801A1 (es) | Formulaciones de anticuerpos y metodos | |
CL2021000415A1 (es) | Vesículas derivadas de lactobacillus paracasei y uso de las mismas | |
ECSP10010548A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
EA201400838A1 (ru) | ЗАМЕЩЕННЫЕ АМИДИНОМ β-ЛАКТАМЫ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В КАЧЕСТВЕ АНТИБАКТЕРИАЛЬНЫХ СРЕДСТВ | |
WO2013075892A3 (de) | Haarkonditionierende mittel | |
CY1124331T1 (el) | Αυξημενη βιοδιαθεσιμοτητα δραστικης ουσιας σε θεραπεια ναλτρεξονης | |
AR101072A1 (es) | Extracto de fermento de una cepa bacteriana para el aumento de los niveles de adiponectina | |
BR112014006455A2 (pt) | alquilamidotiazóis, preparações cosméticas ou dermatológicas com um teor de um ou vários alquilamidotiazóis e uso de um ou vários alquilamidotiazóis | |
BR112015021524A2 (pt) | derivados de sulfonil quinolina e usos dos mesmos | |
MY193312A (en) | Topical formulation for promoting wound healing | |
BR112014002595A2 (pt) | uso de esfinganina para melhorar a aparência visual da pele e cabelo | |
BR112015001697A2 (pt) | formulações de clomazona | |
ECSP16008797A (es) | Derivados de heterobicicloaril como inhibidores rorc2 y métodos de uso de los mismos | |
WO2014179318A3 (en) | Antimicrobials and methods of use thereof for wound healing | |
CL2015000254A1 (es) | Vesículas que comprenden factor de crecimiento epidermico (egf); proceso de preparación; composición farmacéutica que las comprende; y uso para tratar heridas complejas . | |
CY1120860T1 (el) | 2,4 υποκατεστημενες πυριμιδινδιαμινες για χρηση στον δισκοειδη λυκο | |
BR112017019337A2 (pt) | tratamento de dor | |
BR112015014885A2 (pt) | combinação de agentes ativos, composição cosmética e/ou dermatológica e processo para a preparação de uma composição de agentes ativos. | |
BR112014030993A2 (pt) | formulações tópicas, respectivo uso e método para tratar infecção de pele ou ferida | |
BR112017023316A2 (pt) | método cosmético e uso terapêutico para redução de gordura |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25G | Requested change of headquarter approved |
Owner name: DIPEXIUM PHARMACEUTICALS, INC. (US) |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2517 DE 02-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |